id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-355718-7dafsxp9	Leong, Hoe‐Nam	Investigational use of ribavirin in the treatment of severe acute respiratory syndrome, Singapore, 2003	2004-08-10		.txt	text/plain	2714	172	60	title: Investigational use of ribavirin in the treatment of severe acute respiratory syndrome, Singapore, 2003 We performed a retrospective cohort study assessing the effectiveness of ribavirin use in our patients with SARS. We compared the results of clinical and laboratory investigations at the start of ribavirin treatment with correspondent parameters of patients who did not receive ribavirin on day 6 of illness. * Parameters taken on start of treatment for those on ribavirin, and day 6 for the control group. Most patients received this combination therapy but no comparative efficacy data from treatment and control groups were available. After correcting for steroid use, the hazard ratio of death for patients treated with ribavirin was 1.03 (95% CI: 0.44-2.41, P ¼ 0.939). Our study was a retrospective analysis with two groups of patients being treated at different times of the epidemic.	./cache/cord-355718-7dafsxp9.txt	./txt/cord-355718-7dafsxp9.txt